Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. 2011

W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
Department of Psychiatry, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. changwc@hku.hk

BACKGROUND Negative symptoms are a core feature of schizophrenia. The evolution and trajectory of primary negative symptoms were under-studied. We aimed at evaluating the prevalence and stability of primary negative symptoms, and factors associated with persistent primary negative symptoms in a first-episode sample. METHODS Ninety-three Hong Kong Chinese aged 18 to 55 years presenting with first-episode schizophrenia-spectrum disorder were studied. Data on premorbid adjustment, socio-demographics, and baseline clinical and cognitive profiles were obtained. Psychopathological and vocational reassessments were conducted at 12, 24 and 36 months. Primary negative symptoms were defined as the presence of clinically significant negative symptoms excluding depression and extra-pyramidal signs. RESULTS At baseline, 25.8% of subjects exhibited primary negative symptoms. A quarter of patients had their initial primary negative symptoms status retained 12 months after treatment initiation. In both Year 2 and Year 3 of study period, around 70% of subjects had their primary negative symptoms status maintained for 12 months. At the end of three-year follow-up, 23.7% were categorized as having persistent primary negative symptoms. Male sex, unemployment at intake, prolonged duration of untreated psychosis, poorer premorbid academic and social functioning, poorer insight and worse vocational outcome were found to be associated with persistent primary negative symptoms. CONCLUSIONS Clinical status of primary negative symptoms in first-episode schizophrenia-spectrum disorder was unstable in the initial year of treatment. Baseline symptom assessment may not reliably predict development of persistent primary negative symptoms. Studying negative symptoms should take into account the longitudinal perspective, especially in the early course of psychotic disorders.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001526 Behavioral Symptoms Observable manifestations of impaired psychological functioning. Behavioral Symptom,Symptom, Behavioral,Symptoms, Behavioral

Related Publications

W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
September 2014, Schizophrenia research,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
February 1999, The British journal of psychiatry : the journal of mental science,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
November 2017, Schizophrenia research,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
January 1988, Health bulletin,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
December 2002, European archives of psychiatry and clinical neuroscience,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
June 2016, Early intervention in psychiatry,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
April 2013, BMC psychiatry,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
March 2013, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
September 2020, European archives of psychiatry and clinical neuroscience,
W C Chang, and Christy L M Hui, and Jennifer Y M Tang, and Gloria H Y Wong, and May M L Lam, and Sherry K W Chan, and Eric Y H Chen
October 2006, European archives of psychiatry and clinical neuroscience,
Copied contents to your clipboard!